Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Suspension Culture, T Cell
SUBMITTER: Tomáš Oždian
LAB HEAD: Marián Hajdúch
PROVIDER: PXD003543 | Pride | 2017-05-11
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
OxaPt_5xIC50_080408_01.raw | Raw | |||
OxaPt_5xIC50_080408_02.raw | Raw | |||
OxaPt_5xIC50_080408_03.raw | Raw | |||
OxaPt_5xIC50_080408_04.raw | Raw | |||
OxaPt_5xIC50_080408_05.raw | Raw |
Items per page: 5 1 - 5 of 61 |
Ozdian Tomas T Holub Dusan D Maceckova Zuzana Z Varanasi Lakshman L Rylova Gabriela G Rehulka Jiri J Vaclavkova Jana J Slavik Hanus H Moudry Pavel P Znojek Pawel P Stankova Jarmila J de Sanctis Juan Bautista JB Hajduch Marian M Dzubak Petr P
Journal of proteomics 20170503
Oxaliplatin is widely used to treat colorectal cancer in both palliative and adjuvant settings. It is also being tested for use in treating hematological, esophageal, biliary tract, pancreatic, gastric, and hepatocellular cancers. Despite its routine clinical use, little is known about the responses it induces in cancer cells. Therefore the whole-cell proteomics study was conducted to characterize the cellular response induced by oxaliplatin. Chemosensitive CCRF-CEM cells were treated with oxali ...[more]